Related Experiment Video
Updated: Jan 16, 2026

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
Published on: November 12, 2015
Medical interventions for fungal keratitis
Helen Burn1, Nilo Vincent FlorCruz2, Jeremy Hoffman1,3,4
1Department of Ophthalmology, Buckinghamshire Healthcare NHS Trust, Aylesbury, UK.
Objectives:
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of different antifungal drugs (both ocular and systemic) in the medical management of fungal keratitis.
Insights
This review protocol outlines the evaluation of antifungal drugs for fungal keratitis. It aims to compare the benefits and harms of ocular and systemic treatments for this serious eye infection.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Pharmacology
Background:
- Fungal keratitis is a severe corneal infection that can lead to vision loss.
- Antifungal medications are the cornerstone of treatment, but optimal drug selection remains a challenge.
Purpose of the Study:
- To systematically review the efficacy and safety of various antifungal drugs for fungal keratitis.
- To compare the benefits and harms of ocular versus systemic antifungal therapies.
Main Methods:
- This is a protocol for a Cochrane Review.
- The review will synthesize evidence from randomized controlled trials and other relevant studies.
- Data on drug efficacy, adverse events, and visual outcomes will be extracted and analyzed.
Main Results:
- This section will report the findings of the systematic review once data are synthesized.
- Expected results include comparative effectiveness and safety profiles of different antifungal agents.
Conclusions:
- This review will provide evidence-based guidance on the optimal medical management of fungal keratitis.
- Findings will inform clinical decision-making regarding the choice of antifungal drugs.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

